West Midlands Health, Biotech & Nutrition R&D Companies Directory

Cobra Biologics Limited is a contract development and manufacturing organisation (CDMO) specialising in the production of viral vectors and plasmid DNA for gene therapy applications. The company focuses on developing scalable, cost-effective bioprocessing platforms to accelerate the transition of advanced therapies from clinical trials to commercial supply. Their work has evolved from early-stage process development to large-scale infrastructure investment, establishing the UK as a key hub for gene therapy manufacturing.

Bronze Software Labs is a UK technology company specialising in digital platforms for community care, social inclusion, and infrastructure resilience. They combine smart city technologies (geospatial analytics, machine learning) with service design to address inequality in care and support. Their work evolved from urban resilience planning (2015) to connectivity for vulnerable groups (2017) and a large-scale healthy ageing platform (2020/21) that coordinates community resources and care services.

Prokarium is a UK-based biotechnology company developing oral vaccines and immunotherapies using a proprietary live bacterial delivery platform. Their technology initially focused on infectious diseases such as C. difficile, Zika, plague, and enteric fever, later pivoting to cancer immunotherapy by engineering Salmonella bacteria to deliver therapeutic proteins. The platform aims to provide thermostable, self-administered treatments that are cheaper and easier to deploy than injectable alternatives.

The Cell and Gene Therapy Catapult is a specialised innovation centre focused on accelerating the development and commercialisation of advanced therapy medicinal products. It operates as a bridge between academic research and industrial application, providing the infrastructure and expertise required to scale manufacturing processes for cell and gene therapies. Its work involves coordinating large-scale national infrastructure projects to support the UK's life sciences sector.

Harper Adams University is a leading specialist institution in the UK, focusing on agricultural science, engineering, and food production technology. Through its extensive grant history, the university has evolved from fundamental feasibility research into a key partner for developing autonomous robotic systems, precision agronomy, and AI-driven livestock management. Their work bridges the gap between academic research and commercial application, particularly in automating field operations and improving resource efficiency in the food supply chain.

Orbsen Therapeutics is a company involved in the logistics and supply chain for advanced therapy medicinal products (ATMPs), particularly cell and gene therapies. They participate in consortium projects to establish treatment centres and standardise processes for ATMP delivery to patients in the Midlands and Wales, addressing challenges in manufacturing, transport, and NHS deployment.

Arden Biotechnology develops bacteriophage-based biocontrol products to replace antibiotic growth promoters in poultry production. Their technology targets gastrointestinal pathogens like Clostridium perfringens and Enterococcus cecorum, aiming to reduce antimicrobial resistance and improve feed efficiency. The company has progressed from research collaborations to industrial partnerships with major poultry integrators.

Jointmedica is a medical device company developing the Polymotion hip resurfacing system, a biocompatible alternative to metal-on-metal implants. The company focuses on addressing wear and adverse reaction issues in younger, active patients, progressing from early-stage R&D to continuity work during the COVID-19 pandemic.

ErebaGen uses engineered soil bacteria to produce new bioactive natural product compounds with high hit-rates for pharmaceuticals and agrochemicals. Their technology platform harnesses bacterial enzymes evolved by nature, using a patented activator to switch on specialised metabolism. Their work has evolved from a platform for natural product discovery to a focused application in sustainable biocatalysis for aromatic nitration in pharmaceutical manufacturing, and now addresses scale-up challenges for enzyme production.

Earth Rover develops autonomous field robots for precision agriculture, specialising in selective harvesting and herbicide-free weeding using AI-powered vision systems and directed light technology. Their work addresses labour shortages in horticulture and aims to reduce chemical use and food waste.

Upcycled Plant Power develops an on-farm platform to extract food-grade protein and valuable co-products from unutilised broccoli biomass. The company also applies machine learning and automation to improve broccoli harvesting efficiency, yield, and quality, addressing UK agricultural productivity constraints.

Vision Technologies (GiveVision) develops wearable low vision aids that enhance the remaining sight of visually impaired individuals. Their primary device, SightPlus, uses augmented reality to project enhanced images onto the user's eyes, enabling activities such as reading and face recognition. The company has evolved from a proof-of-concept device to a regulated medical device clinically validated at Moorfields Eye Hospital, and is expanding into home-based diagnostics and stadium accessibility.

Zimmer & Peacock is a micro/small enterprise developing decision-support tools and technologies for sustainable agriculture and food production. Their work spans optimising fertiliser use to reduce environmental impact and advancing cultured meat production technologies. They collaborate extensively with academic and industry partners on Innovate UK-funded R&D projects.

Invitron is a micro enterprise based in the West Midlands specialising in point-of-care diagnostic devices. They develop high sensitivity chemiluminescent tests and portable analysers to deliver laboratory-accurate results at the patient bedside, initially targeting cardiac troponin and expanding to chronic disease monitoring. Their work has evolved from early-stage R&D on chemiluminescent compounds to building a portable diagnostic platform.

MESOX develops a novel nanoporous carrier technology to enhance the bioavailability of medicines, combining molecular dynamics simulations, computational fluid dynamics, and digital formulation platforms. Their work spans medicated dressings for diabetic wounds to comprehensive digital design and manufacturing platforms for amorphous solid dispersions and long-acting injectables, targeting improved drug solubility, patient outcomes, and sustainable pharmaceutical manufacturing.

Health Companion develops culturally competent digital self-management platforms for high-risk ethnic minority groups, addressing health inequalities in conditions such as cardiovascular disease, diabetes, and COVID-19. Their work has evolved from pandemic response to broader healthy ageing initiatives, collaborating closely with NHS practices and local authorities.

S&A Produce is a large-scale British soft fruit producer that has evolved from traditional agricultural practices into a technology-driven innovator. The company integrates advanced genomics, machine vision, and autonomous robotics to enhance crop yield, fruit quality, and growing efficiency. Their work bridges the gap between biological research and industrial-scale automation to maintain competitiveness in global fruit markets.

InoCardia is a spin-out from Coventry University that develops human heart-cell based assays for assessing drug-induced cardiotoxicity. Their Work-Loop platform measures cardiac contractility more accurately than animal models, and they have recently integrated AI to create the Contractome-AI platform for predictive safety testing. Their work has evolved from developing the core assay to validating it for early drug discovery and commercialising it with global pharmaceutical customers.

FourPlus Immersive develops virtual and extended reality training platforms primarily for science education and pharmaceutical manufacturing. Their technology enables remote, self-paced learning through immersive simulations and reduces waste from traditional hands-on training in cleanroom environments. They have evolved from a VR platform for university students to a customisable XR platform for medicines manufacturing, collaborating with universities and NHS trusts.

Hope 4 The Community is a Coventry-based social enterprise that develops digital self-management interventions for older adults awaiting hip or knee replacement surgery. Their work focuses on keeping patients physically active, mentally healthy, and socially connected while on NHS waiting lists, with programmes that combine structured physical activity, nutrition guidance, and peer support. The company has evolved from a pilot digital intervention (HoPES) to a scaled community programme (HOPE-MOVE), targeting earlier intervention in musculoskeletal care.